aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. GOOG
6. CSX
7. KNX
8. IBM
9. LVS
10. INTC

Go back to aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting
(NASDAQ: ATYR) Delayed: 0.46 -0.03 (6.12%)
Previous Close $0.49    52 Week High $ 
Open $0.48    52 Week Low $ 
Day High $0.49    P/E N/A 
Day Low $0.46    EPS $ 
Volume 527,908